Advanced search
Publication Cover
OncoImmunology Volume 4, 2015 - Issue 6
Submit an article Journal homepage
4,812
Views
53
CrossRef citations to date
0
Altmetric
Review

Are BiTEs the “missing link” in cancer therapy?

Carter M SuryadevaraDuke Brain Tumor Immunotherapy Program; Division of Neurosurgery; Department of Surgery; Duke University Medical Center; Durham, NC, USA;Department of Pathology; Duke University Medical Center; Durham, NC, USA;The Preston Robert Tisch Brain Tumor Center; Duke University Medical Center; Durham, NC, USACorrespondence[email protected]
,
Patrick C GedeonDuke Brain Tumor Immunotherapy Program; Division of Neurosurgery; Department of Surgery; Duke University Medical Center; Durham, NC, USA;The Preston Robert Tisch Brain Tumor Center; Duke University Medical Center; Durham, NC, USA;Department of Biomedical Engineering; Duke University; Durham, NC, USA
,
Luis Sanchez-PerezDuke Brain Tumor Immunotherapy Program; Division of Neurosurgery; Department of Surgery; Duke University Medical Center; Durham, NC, USA;The Preston Robert Tisch Brain Tumor Center; Duke University Medical Center; Durham, NC, USA
,
Terence VerlaDuke Brain Tumor Immunotherapy Program; Division of Neurosurgery; Department of Surgery; Duke University Medical Center; Durham, NC, USA;The Preston Robert Tisch Brain Tumor Center; Duke University Medical Center; Durham, NC, USA
,
Christopher Alvarez-BreckenridgeDepartment of Neurosurgery; Massachusetts General Hospital and Harvard Medical School; Boston, MA, USA
,
Bryan D ChoiDepartment of Neurosurgery; Massachusetts General Hospital and Harvard Medical School; Boston, MA, USA
,
Peter E FecciDuke Brain Tumor Immunotherapy Program; Division of Neurosurgery; Department of Surgery; Duke University Medical Center; Durham, NC, USA;The Preston Robert Tisch Brain Tumor Center; Duke University Medical Center; Durham, NC, USA
&
John H SampsonDuke Brain Tumor Immunotherapy Program; Division of Neurosurgery; Department of Surgery; Duke University Medical Center; Durham, NC, USA;Department of Pathology; Duke University Medical Center; Durham, NC, USA;The Preston Robert Tisch Brain Tumor Center; Duke University Medical Center; Durham, NC, USA;Department of Biomedical Engineering; Duke University; Durham, NC, USA
 show all
Article: e1008339 | Received 02 Sep 2014, Accepted 08 Jan 2015, Published online: 22 May 2015

Citations (53)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Maxime Jullien, Cyrille Touzeau & Philippe Moreau. (2021) Monoclonal antibodies as an addition to current myeloma therapy strategies. Expert Review of Anticancer Therapy 21:1, pages 33-43.
Read now
Davide Busato, Monica Mossenta, Lorena Baboci, Federica Di Cintio, Giuseppe Toffoli & Michele Dal Bo. (2019) Novel immunotherapeutic approaches for hepatocellular carcinoma treatment. Expert Review of Clinical Pharmacology 12:5, pages 453-470.
Read now
Sergey E Sedykh, Victor V Prinz, Valentina N Buneva & Georgy A Nevinsky. (2018) Bispecific antibodies: design, therapy, perspectives. Drug Design, Development and Therapy 12, pages 195-208.
Read now
Takahiro Yamazaki & Lorenzo Galluzzi. (2017) Blinatumomab bridges the gap between leukemia and immunity. OncoImmunology 6:11.
Read now
Satyen Harish Gohil, Solange Rosa Paredes-Moscosso, Micaela Harrasser, Marzia Vezzalini, Aldo Scarpa, Emma Morris, Andrew M. Davidoff, Claudio Sorio, Amit Chunilal Nathwani & Marco Della Peruta. (2017) An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors. OncoImmunology 6:7.
Read now
Jogender Tushir-Singh. (2017) Antibody-siRNA conjugates: drugging the undruggable for anti-leukemic therapy. Expert Opinion on Biological Therapy 17:3, pages 325-338.
Read now
Françoise Huguet & Suzanne Tavitian. (2017) Emerging biological therapies to treat acute lymphoblastic leukemia. Expert Opinion on Emerging Drugs 22:1, pages 107-121.
Read now

Articles from other publishers (46)

Yunmeng Wang & Ping Cheng. (2024) Arming oncolytic viruses with bispecific T cell engagers: The evolution and current status. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1870:2, pages 166962.
Crossref
Lindsay J. Talbot, Timothy B. Lautz, Jennifer H. Aldrink, Peter F. Ehrlich, Roshni Dasgupta, Peter Mattei, Elisabeth T. Tracy, Richard D. Glick, Christa M. Grant, Erin G. Brown, Emily R. Christison-Lagay & David A. Rodeberg. (2023) Implications of Immunotherapy for Pediatric Malignancies: A Summary from the APSA Cancer Committee. Journal of Pediatric Surgery 58:11, pages 2119-2127.
Crossref
Leila Moeinzadeh, Amin Ramezani, Fereshteh Mehdipour, Mahsa Yazdanpanah-Samani & Mahboobeh Razmkhah. (2023) Activation of T Lymphocytes with Anti-PDL1-BiTE in the Presence of Adipose-Derived Mesenchymal Stem Cells (ASCs). BioMed Research International 2023, pages 1-11.
Crossref
Chaoqun Wang, Yuntao Li, Lijuan Gu, Ran Chen, Hua Zhu, Xu Zhang, Yonggang Zhang, Shi Feng, Sheng Qiu, Zhihong Jian & Xiaoxing Xiong. (2023) Gene Targets of CAR-T Cell Therapy for Glioblastoma. Cancers 15:8, pages 2351.
Crossref
Saru Basnet, Joao M. Santos, Dafne C.A. Quixabeira, James H.A. Clubb, Susanna A.M. Grönberg-Vähä-Koskela, Victor Arias, Santeri Pakola, Tatiana V. Kudling, Camilla Heiniö, Riikka Havunen, Victor Cervera-Carrascon, Suvi Sorsa, Marjukka Anttila, Anna Kanerva & Akseli Hemminki. (2023) Oncolytic adenovirus coding for bispecific T cell engager against human MUC-1 potentiates T cell response against solid tumors. Molecular Therapy - Oncolytics 28, pages 59-73.
Crossref
Wan-Soo Yoon & Dong-Sup Chung. (2023) Advanced T and NK Cell Therapy for Glioblastoma. Journal of Korean Neurosurgical Society.
Crossref
Jyoti Malhotra & Edward S. Kim. (2022) Oncolytic Viruses and Cancer Immunotherapy. Current Oncology Reports 25:1, pages 19-28.
Crossref
Luigi Liguori, Giovanna Polcaro, Annunziata Nigro, Valeria Conti, Carmine Sellitto, Francesco Perri, Alessandro Ottaiano, Marco Cascella, Pio Zeppa, Alessandro Caputo, Stefano Pepe & Francesco Sabbatino. (2022) Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors. Pharmaceutics 14:11, pages 2442.
Crossref
Ramazan Rezaei, Hadi Esmaeili Gouvarchin Ghaleh, Mahdieh Farzanehpour, Ruhollah Dorostkar, Reza Ranjbar, Masoumeh Bolandian, Majid Mirzaei Nodooshan & Akbar Ghorbani Alvanegh. (2021) Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy. Cancer Gene Therapy 29:6, pages 647-660.
Crossref
Amirhossein Mardi, Anastasia V. Shirokova, Rebar N. Mohammed, Ali Keshavarz, Angelina O. Zekiy, Lakshmi Thangavelu, Talar Ahmad Merza Mohamad, Faroogh Marofi, Navid Shomali, Amir Zamani & Morteza Akbari. (2022) Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction. Cancer Cell International 22:1.
Crossref
Gianluca Selvaggio, Silvia Parolo, Pranami Bora, Lorena Leonardelli, John Harrold, Khamir Mehta, Dan A. Rock & Luca Marchetti. (2022) Computational Analysis of Cytokine Release Following Bispecific T-Cell Engager Therapy: Applications of a Logic-Based Model. Frontiers in Oncology 12.
Crossref
Elena K. Davydova. (2022) Protein Engineering: Advances in Phage Display for Basic Science and Medical Research. Biochemistry (Moscow) 87:S1, pages S146-S167.
Crossref
Hany E. Marei, Asmaa Althani, Nahla Afifi, Anwarul Hasan, Thomas Caceci, Giacomo Pozzoli & Carlo Cenciarelli. (2021) Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme. Cancer Medicine 10:15, pages 5019-5030.
Crossref
Neha N. Parayath & Matthias T. Stephan. (2021) In Situ Programming of CAR T Cells. Annual Review of Biomedical Engineering 23:1, pages 385-405.
Crossref
Lien Van Hoecke, Rein Verbeke, Heleen Dewitte, Ine Lentacker, Karim Vermaelen, Karine Breckpot & Sandra Van Lint. (2021) mRNA in cancer immunotherapy: beyond a source of antigen. Molecular Cancer 20:1.
Crossref
Sophia Khaldoyanidi, Dirk Nagorsen, Anthony Stein, Gerrit Ossenkoppele & Marion Subklewe. (2021) Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy. Journal of Clinical Oncology 39:5, pages 419-432.
Crossref
Kerstin Menck, Saskia Heinrichs, Cornelia Baden & Annalen Bleckmann. (2021) The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention. Cells 10:1, pages 142.
Crossref
Ali Akbar Samadani, Arman Keymoradzdeh, Shima Shams, Armin Soleymanpour, Ali Rashidy-Pour, Houman Hashemian, Sogand Vahidi & Seyedeh Elham Norollahi. (2021) CAR T-cells profiling in carcinogenesis and tumorigenesis: An overview of CAR T-cells cancer therapy. International Immunopharmacology 90, pages 107201.
Crossref
Wenhao Luo, Lianfang Zheng & Taiping Zhang. (2021) Do novel treatment strategies enhance T cell-mediated Immunity: Opportunities and challenges in pancreatic cancer immunotherapy. International Immunopharmacology 90, pages 107199.
Crossref
N. N. Parayath, S. B. Stephan, A. L. Koehne, P. S. Nelson & M. T. Stephan. (2020) In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo. Nature Communications 11:1.
Crossref
Chang-Myung Oh, Hong Jae Chon & Chan Kim. (2020) Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors. International Journal of Molecular Sciences 21:20, pages 7743.
Crossref
Anne M. Macpherson, Simon C. Barry, Carmela Ricciardelli & Martin K. Oehler. (2020) Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy. Journal of Clinical Medicine 9:9, pages 2967.
Crossref
Massimo Giuliani & Alessandro Poggi. (2020) Checkpoint Inhibitors and Engineered Cells: New Weapons for Natural Killer Cell Arsenal Against Hematological Malignancies. Cells 9:7, pages 1578.
Crossref
Shyambabu Chaurasiya, Yuman Fong & Susanne G. Warner. (2020) Optimizing Oncolytic Viral Design to Enhance Antitumor Efficacy: Progress and Challenges. Cancers 12:6, pages 1699.
Crossref
Arne Krüger, Vinicius Gonçalves Maltarollo, Carsten Wrenger & Thales Kronenberger. 2020. Drug Discovery and Development - New Advances. Drug Discovery and Development - New Advances.
Rebecca C. Abbott, Ryan S. Cross & Misty R. Jenkins. (2020) Finding the Keys to the CAR: Identifying Novel Target Antigens for T Cell Redirection Immunotherapies. International Journal of Molecular Sciences 21:2, pages 515.
Crossref
Dalma Deak, Cristina Pop, Alina-Andreea Zimta, Ancuta Jurj, Alexandra Ghiaur, Sergiu Pasca, Patric Teodorescu, Angela Dascalescu, Ion Antohe, Bogdan Ionescu, Catalin Constantinescu, Anca Onaciu, Raluca Munteanu, Ioana Berindan-Neagoe, Bobe Petrushev, Cristina Turcas, Sabina Iluta, Cristina Selicean, Mihnea Zdrenghea, Alina Tanase, Catalin Danaila, Anca Colita, Andrei Colita, Delia Dima, Daniel Coriu, Hermann Einsele & Ciprian Tomuleasa. (2019) Let’s Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia. Frontiers in Immunology 10.
Crossref
Mariana Franzoni Maioral, Natália Marceli Stefanes, Álisson Bigolin, Gabriele Andressa Zatelli, Ana Cláudia Philippus, Miriam de Barcellos Falkenberg & Maria Cláudia Santos-Silva. (2018) MICONIDINE acetate, a new selective and cytotoxic compound with synergic potential, induces cell cycle arrest and apoptosis in leukemia cells. Investigational New Drugs 37:5, pages 912-922.
Crossref
Selena J. Lorrey, Luis Sanchez-Perez & Peter E. Fecci. (2019) Rescuing imperfect antigens for immuno-oncology. Nature Biotechnology 37:9, pages 1002-1003.
Crossref
Adam Ajina & John Maher. 2019. Cancer Immunotherapy. Cancer Immunotherapy 217 292 .
Cynthia Kassab, Brittany Parker Kerrigan, Hillary Caruso, Sanaalarab Al Enazy & Amy B. Heimberger. 2019. Nervous System Drug Delivery. Nervous System Drug Delivery 297 334 .
Stacy L. Cooper & Patrick A. Brown. 2019. Resistance to Targeted Therapies in Lymphomas. Resistance to Targeted Therapies in Lymphomas 181 192 .
Charlotte U. Brey, Julia Proff, Natascha Teufert, Benjamin Salzer, Johannes Brozy, Markus Münz, Jochen Pendzialek, Armin Ensser, Wolfgang Holter & Manfred Lehner. (2018) A gB/CD3 bispecific BiTE antibody construct for targeting Human Cytomegalovirus-infected cells. Scientific Reports 8:1.
Crossref
Laura R. Díaz, Elena Saavedra-López, Leire Romarate, Izaskun Mitxitorena, Paola V. Casanova, George P. Cribaro, José M. Gallego, Ana Pérez-Vallés, Jerónimo Forteza-Vila, Clara Alfaro-Cervello, José M. García-Verdugo, Carlos BarciaSr.Sr. & Carlos BarciaJr.Jr.. (2018) Imbalance of immunological synapse-kinapse states reflects tumor escape to immunity in glioblastoma. JCI Insight 3:18.
Crossref
Jillian Rosenberg & Jun Huang. (2018) CD8+ T cells and NK cells: parallel and complementary soldiers of immunotherapy. Current Opinion in Chemical Engineering 19, pages 9-20.
Crossref
Kristen A. Batich, Alexa N. Bramall, Carter M. Suryadevara & John H. Sampson. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy 693 705 .
David Bakhshinyan, Ashley A. Adile, Maleeha A. Qazi, Mohini Singh, Michelle M. Kameda-Smith, Nick Yelle, Chirayu Chokshi, Chitra Venugopal & Sheila K. Singh. 2018. Cancer Stem Cells. Cancer Stem Cells 1 16 .
Shengnan Yu, Anping Li, Qian Liu, Xun Yuan, Hanxiao Xu, Dechao Jiao, Richard G. Pestell, Xinwei Han & Kongming Wu. (2017) Recent advances of bispecific antibodies in solid tumors. Journal of Hematology & Oncology 10:1.
Crossref
Michael Zorniak, Paul A. Clark, Benjamin J. Umlauf, Yongku Cho, Eric V. Shusta & John S. Kuo. (2017) Yeast display biopanning identifies human antibodies targeting glioblastoma stem-like cells. Scientific Reports 7:1.
Crossref
Sara Sandri, Francesco De Sanctis, Alessia Lamolinara, Federico Boschi, Ornella Poffe, Rosalinda Trovato, Alessandra Fiore, Sara Sartori, Andrea Sbarbati, Attilio Bondanza, Simone Cesaro, Mauro Krampera, Maria T. Scupoli, Michael I. Nishimura, Manuela Iezzi, Silvia Sartoris, Vincenzo Bronte & Stefano Ugel. (2017) Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy. Oncotarget 8:50, pages 86987-87001.
Crossref
Hok Seon Kim, Diana Ronai Dunshee, Angie Yee, Raymond K Tong, Ingrid Kim, Farzam Farahi, Jo-Anne Hongo, James A Ernst, Junichiro Sonoda & Christoph Spiess. (2017) Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screening. Protein Engineering, Design and Selection 30:9, pages 627-637.
Crossref
Dominique Bollino & Tonya J. Webb. (2017) Chimeric antigen receptor–engineered natural killer and natural killer T cells for cancer immunotherapy. Translational Research 187, pages 32-43.
Crossref
Kristina Ellwanger, Uwe Reusch, Ivica Fucek, Stefan Knackmuss, Michael Weichel, Thorsten Gantke, Vera Molkenthin, Eugene A. Zhukovsky, Michael Tesar & Martin Treder. (2017) Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies. Frontiers in Oncology 7.
Crossref
Huan-huan Sha, Dan-dan Wang, Da-li Yan, Yong Hu, Su-jin Yang, Si-wen Liu & Ji-feng Feng. (2017) Chimaeric antigen receptor T-cell therapy for tumour immunotherapy. Bioscience Reports 37:1.
Crossref
Alain C. Tissot & Ulrich Brinkmann. 2017. Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases. Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases 75 97 .
Brian T. Rekoske & Douglas G. McNeel. (2016) Immunotherapy for prostate cancer: False promises or true hope?. Cancer 122:23, pages 3598-3607.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.